A clinically significant drug interaction between warfarin and amoxicillin resulting in persistent postoperative bleeding in a dental patient

General Dentistry

Volumn 61, Issue 4, 2013, Pages 50-54

  Goodchild, Jason H ^a,b,c   Donaldson, Mark ^d,e,f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^c Kalispell Regional Medical Center ^*

^d KALISPELL REGIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF MONTANA   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Amoxicillin; Bleeding; International normalized ratio; Warfarin

Indexed keywords

AMOXICILLIN; ANTICOAGULANT AGENT; WARFARIN;

DRUG INTERACTION; HUMAN; INTERNATIONAL NORMALIZED RATIO;

AMOXICILLIN; ANTICOAGULANTS; DRUG INTERACTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; WARFARIN;

EID: 84881490112     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Proceedings of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines. Chest. 2004;126(3 Suppl):172S-696S.
2. Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J. 1996; 132(5):1095-1100.
3. Nutescu EA. The future of anticoagulation clinics. J Thromb Thrombolysis. 2003;16(1-2):61-63.
4. Witte K, Gurwich EL, Anzalone R, Campagna MA. Audit of an oral anticoagulant teaching program. Am J Hosp Pharm. 1980;37(1): 89-91.
5. Finck KM, Doetkott C, Miller DR. Clinical impact of interlaboratory variation in international normalized ratio determinations. Am J Health-Syst Pharm. 2001; 58(8):684-688.
6. Griffin BL, Burkiewicz JS, Peppers LR, Wartholak TL. International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic. Am J Health-Syst Pharm. 2009; 66(13):1218-1223.
7. Bungard TJ, Gardner L, Archer SL, et al. Evaluation of a pharmacist-managed anticoagulation clinic: improving patient care. Open Med. 2009;3(1):e16-e21.
8. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158(15):1641-1647.
9. Donaldson M, Sullivan J, Norbeck A. Comparison of International Normalized Ratios provided by two point-of-care devices and laboratory-based venipuncture in a pharmacist-managed anticoagulation clinic. Am J Health Syst Pharm. 2010;67(19):1616-1622.
10. Greenberg MS, Glick M, Ship JA. Burket's Oral Medicine. 11th ed. Hamilton, Ontario: Decker Inc; 2008: 422-434.
11. Lockhart PB, Gibson J, Pond SH, et al. Dental management considerations for the patient with an acquired coagulopathy. Part 1: coagulopathies from systemic disease. Br Dent J. 2003;195(8):439-445.
12. Lockhart PB, Gibson J, Pond SH, Leitch J. Dental management considerations for the patient with an acquired coagulopathy. Part 2: coagulopathies from drugs. Br Dent J. 2003;195(9):495-501.
13. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl):299S-339S.
14. Nematullah A, Alabousi A, Blanas N, Douketis JD, Sutherland SE. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc. 2009;75(1):41.
15. Jeske AH, Suchko GD; ADA Council on Scientific Affairs and Division of Science, Journal of the American Dental Association. Lack of a scientific basis for routine discontinuation of anticoagulant therapy before dental treatment. J Am Dent Assoc. 2003;134(11):1492-1497.
16. Erratum in J Am Dent Assoc. 2004;135(1):28
17. Ferrieri GB, Castiglioni S, Carmagnola D, Cargnel M, Strohmenger L, Abati S. Oral surgery in patients on anticoagulant treatment without therapy interruption. J Oral Maxillofac Surg. 2007;65(6):1149-1154.
18. Aframian DJ, Lalla RV, Peterson DE. Management of dental patients taking common hemostasis-altering medications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl):S45.e1-e11.
19. Herman WW, Konzelman JL Jr, Sutley SH. Current perspectives on dental patients receiving coumarin anticoagulant therapy. J Am Dent Assoc. 1997;128(3): 327-335.
20. Goodchild JH, Donaldson M. An evidence-based dentistry challenge: treating patients on warfarin (Coumadin). Dent Implantol Update. 2009;20(1):1-8.
21. Tyler MT. Clinicians Guide to Treatment of Medically Compromised Dental Patients. Hamilton, Ontario: BC Decker; 2001:3-4.
22. Harder S, Thurmann P. Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet. 1996;30(6):416-444.
23. Jacobs LG. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. Clin Geriatr Med. 2006;22(1):17-32, vii-viii.
24. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61(15):2163-2175.
25. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother. 2000;34(12):1478-1482.
26. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121(9):676-683.
27. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095-1106.
28. Baillargeon J, Holmes HM, Lin YL, Raji MA, Sharma G, Kuo YF. Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med. 2012; 125(2):183-189.
29. Wolters Kluwer. Lexicomp Online User Guide. Available at: http://online.lexi.com/lco/help/lco-ug.pdf. Accessed April 23, 2013.
30. Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119(1 Suppl): 8S-21S.
31. Harder S, Thurmann P. Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet. 1996;30(6):416-444.
32. Bristol-Myers Squibb Company. Coumadin [prescribing information]. Available at: http://www.coumadin.com/html/index.htm. Accessed April 23, 2013.
33. Garcia D, Regan S, Henault LE, et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med. 2008;168(1):63-69.
34. Little JW, Miller CS, Henry RG, McIntosh BA. Antithrombotic agents: implications in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(5): 544-551.
35. Fischer HD, Juurlink DN, Mamdani M, Kopp A, Laupacis A. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population based study. Arch Intern Med. 2010;170(7):617-621.
36. Rindone JP, Kelley CL, Jones WN, Garewal HS. Hypoprothrombinemic effect of warfarin not influenced by ciprofloxacin. Clin Pharm. 1991;10(2):136-138.
37. Bianco TM, Bussey HI, Farnett LE, Linn WD, Roush MK, Wong YW. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation. Pharmacotherapy. 1992;12:435-439.
38. Israel DS, Stotka J, Rock W, et al. Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin. Clin Infect Dis. 1996;22(2):251-256.
39. Foster DR, Milan NL. Potential interaction between azithromycin and warfarin. Pharmacotherapy. 1999; 19(7):902-908.
40. Shrader SP, Fermo JD, Dzikowski AL. Azithromycin and warfarin interaction. Pharmacotherapy. 2004;24(7): 945-949.
41. Hasan SA. Interaction of doxycycline and warfarin: an enhanced anticoagulant effect. Cornea. 2007;26(6): 742-743.
42. Glasheen JJ, Fugit RV. How warfarin interacts with common antibiotics. Emerg Med. 2004;36:30C-30I.
43. Beckey NP, Parra D, Colon A. Retrospective evaluation of a potential interaction between azithromycine and warfarin in patients stabilized on warfarin. Pharmacotherapy. 2000;20(9):1055-1059.
44. Glasheen JJ, Fugit RV, Prochazka AV. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med. 2005; 20(7):653-656.
45. McCall KL, Anderson HG, Jones AD. Determination of the lack of a drug interaction between azithromycin and warfarin. Pharmacotherapy. 2004;24(2):188-194.
46. Schelleman H, Bilker WB, Brensinger CM, Han X, Kimmel SE, Hennessy S. Warfarin, fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. Clin Pharmacol Ther. 2008;84(5):581-588.
47. Zhang K, Young C, Berger J. Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions. J Manag Care Pharm. 2006;12(8): 640-648.
48. Ghaswalla PK, Harpe SE, Tassone D, Slattum PW. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic. Am J Geriatr Pharmacother. 2012;10(6):352-360.
49. GlaxoSmithKline Company. Amoxil [prescribing information]. Available at: http://www.meppo.com/pdf/drugs/134-AMOXIL-1329640288.pdf. Accessed April 23, 2013.
50. Vitry AI, Roughead EE, Ramsay EN, et al. Major bleeding risk associated with warfarin and co-medications in the elderly population. Pharmacoepidemiol Drug Saf. 2011;20(10):1057-1063.
51. Warfarin users, beware of antibiotics. Interactions may increase the risk of internal bleeding. Harv Heart Lett. 2012;22(10):3.
52. Aldous JA, Olson CJ. Managing patients on warfarin therapy: a case report. Spec Care Dentist. 2008;21(3): 109-112.